Federal Investigation of ARDS Study (Accute Respiratory Distress)

Federal Investigation of ARDS Study (Accute Respiratory Distress) OHRP conducted a compliance oversight evaluation of the 12 major sites participating in this clinical trial. OHRP’s determination letters documenting the outcomes of these evaluations can be viewed at the OHRP website at the following URLs: Note: OHRP found that federal informed…

Yale Complaint

ALLIANCE FOR HUMAN RESEARCH PROTECTION* (AHRP) April 10, 2000 Gary Ellis, Ph.D, Director Michael A. Carome, M.D. Chief Compliance Oversight Branch Division of Human Subject Protections Office of Protection from Research Risks Rockville, MD 20892-7507 Re: High Risk Experiment With Children Who Have No Medical Diagnosis Dear Dr. Ellis &…

AHRP Comments Re: EPA Proposed Rule for Human Pesticide Research

AHRP Comments Re: EPA Proposed Rule for Human Pesticide Research Wed, 30 Nov 2005 Help us stop a proposed government policy that would lead to the proliferation of unthinkable human pesticide experiments such as the infamous CHEERS experiment. CHEERS was designed to expose toddlers to pesticides so that EPA investigators…

Schizophrenia Drug Implants May Qualify as Medical Torture

Schizophrenia Drug Implants May Qualify as Medical Torture Sun, 17 Nov 2002 In some patients, antipsychotic drugs induce excruciating, intolerable side-effects. In some people these drugs’ toxic action has caused severe liver, heart, and kidney damage, as well as dangerously high blood pressure– some patients have died as a result…

Death of Baby Prompts Scrutiny of Research Risks_St. Louis Post Dispatch

Death of Baby Prompts Scrutiny of Research Risks_St. Louis Post Dispatch 16 Feb 2003 Eighteen month old, Daniella Rogers, died on May 3, 2002, two months after undergoing a clinical trial of chemotherapy treatments at St. Louis Children’s Hospital. When her parents, John and Oksana Rogers, learned that their baby…

Infomail Archive 2005

Infomail 2005 News Stories on Human Research Protection and Commentary by Vera Hassner Sharav Subscribe to the AHRP infomail list Dec 16: Drugs, Devices & Doctors – NYT Paul Krugman Dec 11: Scientific Fraud & Corruption on Both sides of Atlantic: Merck / Proctor & Gamble Dec 11: Gov Accountability…

AHRP Files Court Brief to Protect Children from Harmful Research

October 1, 2001 Text of AHRP Amicus Brief filed with the Maryland Court of Appeals in support of the Court’s ruling against Kennedy Krieger Institute for exposing children to lead poison in an experiment. The Court of Appeals Decision Validates AHRP’s Stand Against Using Children in Harmful Research Experiments. ___________________________________________________…

Pilots/ Children prescribed addictive stimulant drugs

Pilots/ Children prescribed addictive stimulant drugs – “go pills” / “no go pills” – Christian Sci Monitor Fri, 20 Sep 2002 The Christian Science Monitor (below) reveals that performance-enhancing drug use by US military personnel is likely to escalate. To stay awake during long range bombing missions, U.S. pilots use…

US Research Community May Take Lessons in Medical Ethics from Cambodian Prostitutes

US Research Community May Take Lessons in Medical Ethics from Cambodian Prostitutes Thu, 12 Aug 2004 The US medical research community may have to take lessons in medical ethics from Cambodian prostitutes. A clinical trial to test a drug used to treat HIV, Viread, for the prevention of AIDS, was…

Children are Humans: Don’t Sacrifice their Rights, Dignity & Welfare

ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) Tel. 212-595-8974 Fax: 212-595-9086 142 West End Ave. Suite 28P New York, NY 10023 Co-founders: Vera Hassner Sharav, President John H. Noble, Jr., PhD, Treasurer David Cohen, Ph.D., Secretary March 27, 2003 March 27, 2003 Senate Committee on Health, Education, Labor, and Pensions Dear…

FDA: Regulatory Protections for Children. Comments by Sharav, Noble, & Fishman for AHRP

FDA: regulatory protections for children. Comments submitted by Vera Hassner Sharav, John H. Noble, Jr., Ph.D and Howard Fishman, MEd, MSW for AHRP August 6, 2001 To: Dr. Bernard Schwetz Acting Commissioner Food and Drug Administration Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville,…